Further analysis of CD8+ T cells from tumor tissues demonstrated the enrichment of IFN-γ response and T cell activation gene signature pathways in tumor-infiltrating CD8+ T cells with lower RIG-I expression compared with tumor-infiltrating CD8+ T cells with higher RIG-I expression (Figure 8, C and D). The gene discussed is CD8A; the disease is neoplasm.